Werewolf Therapeutics (HOWL) eyes 2026 catalysts following FDA guidance and encouraging INDUKINE results

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) is included on our list of stocks under $1 that will explode. On December 18, 2025, ...
Fintel on MSN

Werewolf Therapeutics (HOWL) price target decreased by 10.86% to 5.30

The average one-year price target for Werewolf Therapeutics (NasdaqGS:HOWL) has been revised to $5.30 / share. This is a ...
collider

Best Werewolf Films, from The Howling to Werewolves Within

Matthew Galea is a features writer for CBR. He spends his day as a high school English teacher, and every other minute watching, thinking and writing about movies and television. From Lon Chaney Jr.'s ...
collider

Sorry, but There’s Only One Truly Scary Werewolf Movie, and It Was Made 43 Years Ago

Horror has a plethora of subgenres, from slashers and zombies, to ghosts and vampires, and many more. An underappreciated subgenre is the werewolf film. Although there were classics like The Wolfman ...
Yahoo

Werewolf Captain America Returns for New Howling Commandos Marvel Series

Werewolf Captain America is returning for a new Marvel Comics limited series, Capwolf & The Howling Commandos. Announced exclusively by AIPT Comics, Capwolf & The Howling Commandos is a four-issue ...
Yahoo Finance

Werewolf Therapeutics (HOWL) Eyes 2026 Catalysts Following FDA Guidance and Encouraging INDUKINE Results

On December 18, 2025, Werewolf Therapeutics, Inc. (NASDAQ:HOWL) shared a comprehensive pipeline update in which it highlighted clinical progress and 2026 priorities for its INDUKINE programs and ...